Año: 2021
Journal Impact Factor (JIF): 7.088
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
CHEMISTRY, MEDICINAL | SCIE | 5/63 | Q1 | T1 | D1 |
Año:
2021
CiteScore:
11.200
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Drug Discovery | 14/154 | Q1 | T1 | D1 |
Organic Chemistry | 11/192 | Q1 | T1 | D1 |
Pharmacology | 23/303 | Q1 | T1 | D1 |
SJR año:
2021
Factor de Impacto:
1.054
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Drug Discovery | 23/153 | Q1 | T1 | D2 |
Medicine (miscellaneous) | 424/2488 | Q1 | T1 | D2 |
Organic Chemistry | 23/181 | Q1 | T1 | D2 |
Pharmacology | 63/316 | Q1 | T1 | D2 |
Agencia | Código de Proyecto |
---|---|
- | PID2020-116460RB-I00; MCIN/AEI/10.13039/501100011033 |
Canary Islands ACIISI | TESIS2020010055 |
Canary Islands Government (ACIISI/FEDER, UE) | ProID2020010101 |
COST Action STRATAGEM -"New diagnostic and therapeutic tools against multidrug resistant tumors" | CA17104 |
EU Social Fund (FSE) | TESIS2020010055 |
Junta de Andalucia | FQM134 |
Ministry of Education, Science and Technological Development of the Republic of Serbia | 451-03-9/2021-14/200007 |
Spanish Government (MCIU/AEI/FEDER, UE) | PGC2018-094503-B-C22 |
# | Autor | Afiliación |
---|---|---|
1 | Hicke, Francisco J. | Universidad de Sevilla (Spain) |
2 | Puerta, Adrián | Universidad de la Laguna (Spain) |
3 | Dinić, Jelena | University of Belgrade (Serbia) |
4 | University of Belgrade (Serbia) | |
5 | Universidad de la Laguna (Spain) | |
6 | Universidad de Sevilla (Spain) | |
7 | Universidad de Sevilla (Spain) |